Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net revenue	$ 3,260,975	$ 3,200,177	$ 2,970,595
Revenue, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
Costs and expenses:
Cost of net revenue	$ 2,579,882	$ 2,576,110	$ 2,390,480
Cost, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
General and administrative expenses	$ 359,238	$ 334,594	$ 324,814
Depreciation and amortization, excluding patient equipment depreciation	45,045	57,087	64,890
Goodwill impairment (note 7)	13,078	830,787	0
Total costs and expenses	2,997,243	3,798,578	2,780,184
Operating income (loss)	263,732	(598,401)	190,411
Interest expense, net	126,668	130,299	109,414
Loss on extinguishment of debt	2,273	0	0
Change in fair value of warrant liability (note 13)	(4,021)	(34,482)	(17,158)
Other loss, net	2,793	29,566	253
Income (loss) before income taxes	136,019	(723,784)	97,902
Income tax expense (benefit)	41,239	(49,004)	24,769
Net income (loss)	94,780	(674,780)	73,133
Income attributable to noncontrolling interest	4,358	4,115	3,817
Net income (loss) attributable to AdaptHealth Corp.	$ 90,422	$ (678,895)	$ 69,316
Weighted average common shares outstanding - basic (in shares)	133,756	134,156	134,175
Weighted average common shares outstanding - diluted (in shares)	135,531	134,418	138,988
Basic net income (loss) per share (note 12) (in dollars per share)	$ 0.62	$ (5.06)	$ 0.47
Diluted net income (loss) per share (note 12) (in dollars per share)	$ 0.61	$ (5.31)	$ 0.33